Published in Clin Vaccine Immunol on October 01, 2006
Diagnosis of visceral leishmaniasis: developments over the last decade. Parasitol Res (2011) 1.21
The evolution of amastin surface glycoproteins in trypanosomatid parasites. Mol Biol Evol (2010) 1.10
The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models. DNA Res (2013) 1.06
Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins. PLoS One (2013) 0.92
Deadenylation-independent stage-specific mRNA degradation in Leishmania. Nucleic Acids Res (2008) 0.92
Trypanosoma cruzi: role of δ-amastin on extracellular amastigote cell invasion and differentiation. PLoS One (2012) 0.89
The Comparative Genomics and Phylogenomics of Leishmania amazonensis Parasite. Evol Bioinform Online (2014) 0.83
Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes. PLoS Pathog (2015) 0.78
Distinct genomic organization, mRNA expression and cellular localization of members of two amastin sub-families present in Trypanosoma cruzi. BMC Microbiol (2013) 0.78
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis. Antimicrob Agents Chemother (2014) 0.75
Use of recombinant antigens for sensitive serodiagnosis of American tegumentary leishmaniasis caused by different Leishmania species. J Clin Microbiol (2016) 0.75
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Diagnostics for the developing world. Nat Rev Microbiol (2004) 5.62
The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol (2000) 3.92
Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg (1993) 2.93
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis (1996) 2.93
Leishmaniasis: new approaches to disease control. BMJ (2003) 2.30
The IgG Fc receptor family. Ann Hematol (1998) 2.28
Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. Mol Biochem Parasitol (2005) 1.30
Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. J Immunol (2002) 1.30
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol (2001) 1.29
An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis. Am J Trop Med Hyg (1983) 1.26
Class and subclass selection in parasite-specific antibody responses. Trends Parasitol (2003) 1.21
Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design. Trends Immunol (2003) 1.20
Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull World Health Organ (1999) 1.16
A new developmentally regulated gene family in Leishmania amastigotes encoding a homolog of amastin surface proteins. Mol Biochem Parasitol (2000) 1.16
Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis (1993) 1.15
Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol (1998) 1.13
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin Exp Immunol (1994) 1.06
Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn Microbiol Infect Dis (2002) 1.03
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03
From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine (2005) 1.02
Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp Parasitol (2003) 0.97
Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis. Microbes Infect (2006) 0.97
Recombinant DNA-derived leishmania proteins: from the laboratory to the field. Lancet Infect Dis (2005) 0.97
The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host. Ann Parasitol Hum Comp (1990) 0.96
Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis. J Clin Microbiol (1996) 0.90
Leucine rich repeats are the main epitopes in Leishmania infantum PSA during canine and human visceral leishmaniasis. Parasite Immunol (2000) 0.88
A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry. FEBS Lett (1997) 0.88
Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis. Diagn Microbiol Infect Dis (2003) 0.87
Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat (2004) 1.96
Developmental regulation of gene expression in trypanosomatid parasitic protozoa. Curr Opin Microbiol (2007) 1.80
Prefractionation by digitonin extraction increases representation of the cytosolic and intracellular proteome of Leishmania infantum. J Proteome Res (2006) 1.65
Members of a large retroposon family are determinants of post-transcriptional gene expression in Leishmania. PLoS Pathog (2007) 1.59
A common mechanism of stage-regulated gene expression in Leishmania mediated by a conserved 3'-untranslated region element. J Biol Chem (2002) 1.48
Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species. BMC Genomics (2008) 1.47
Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol (2008) 1.38
Measuring social participation: reliability of the LIFE-H in older adults with disabilities. Disabil Rehabil (2004) 1.31
Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. Mol Biochem Parasitol (2005) 1.30
Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol Biochem Parasitol (2009) 1.28
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies. Exp Parasitol (2010) 1.25
A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics (2006) 1.24
Distinct 3'-untranslated region elements regulate stage-specific mRNA accumulation and translation in Leishmania. J Biol Chem (2005) 1.24
Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway. Sci Signal (2011) 1.24
Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother (2005) 1.24
Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res (2011) 1.23
Coordinated gene expression by post-transcriptional regulons in African trypanosomes. J Biol (2009) 1.17
Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res (2003) 1.16
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun (2005) 1.11
Formation of linear inverted repeat amplicons following targeting of an essential gene in Leishmania. Nucleic Acids Res (2005) 1.11
Predictors of long-term participation after stroke. Disabil Rehabil (2006) 1.09
Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot Cell (2006) 1.09
Promastigote to amastigote differentiation of Leishmania is markedly delayed in the absence of PERK eIF2alpha kinase-dependent eIF2alpha phosphorylation. Cell Microbiol (2011) 1.06
Organization and evolution of two SIDER retroposon subfamilies and their impact on the Leishmania genome. BMC Genomics (2009) 1.04
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals. Vaccine (2008) 1.00
A novel class of developmentally regulated noncoding RNAs in Leishmania. Eukaryot Cell (2006) 0.98
Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice. Clin Vaccine Immunol (2011) 0.98
A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol Microbiol (2005) 0.97
Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin Immunol (2004) 0.95
Role of transposable elements in trypanosomatids. Microbes Infect (2008) 0.93
Comparison of changes in upper and lower extremity impairments and disabilities after stroke. Int J Rehabil Res (2003) 0.93
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis. Vaccine (2009) 0.93
Deadenylation-independent stage-specific mRNA degradation in Leishmania. Nucleic Acids Res (2008) 0.92
Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice. Infect Immun (2003) 0.92
Validity of the Assessment of Life Habits in older adults. J Rehabil Med (2004) 0.92
Synergizing expectation and execution for stroke communities of practice innovations. Implement Sci (2010) 0.92
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection. J Control Release (2011) 0.91
Analysis of stage-specific expression of basic proteins in Leishmania infantum. J Proteome Res (2010) 0.91
Translational control through eIF2alpha phosphorylation during the Leishmania differentiation process. PLoS One (2012) 0.90
Comparison of two functional independence scales with a participation measure in post-stroke rehabilitation. Arch Gerontol Geriatr (2003) 0.90
Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. J Immunol (2004) 0.89
Development and validation of a scale for rating motor compensations used for reaching in patients with hemiparesis: the reaching performance scale. Phys Ther (2004) 0.89
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis. PLoS Negl Trop Dis (2013) 0.89
Rapid decay of unstable Leishmania mRNAs bearing a conserved retroposon signature 3'-UTR motif is initiated by a site-specific endonucleolytic cleavage without prior deadenylation. Nucleic Acids Res (2010) 0.89
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis. Vaccine (2004) 0.89
Impact of wheelchair acquisition on social participation. Disabil Rehabil Assist Technol (2009) 0.88
Participation after stroke compared to normal aging. J Rehabil Med (2005) 0.88
The ribosomal RNA gene promoter and adjacent cis-acting DNA sequences govern plasmid DNA partitioning and stable inheritance in the parasitic protozoan Leishmania. Nucleic Acids Res (2004) 0.88
Effect of a home leisure education program after stroke: a randomized controlled trial. Arch Phys Med Rehabil (2007) 0.88
Falling through the cracks: a literature review to understand the reality of mild stroke survivors. Top Stroke Rehabil (2010) 0.86
Clinicians' expectations of Web 2.0 as a mechanism for knowledge transfer of stroke best practices. J Med Internet Res (2012) 0.86
A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics (2002) 0.86
In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol (2006) 0.85
Improving the prediction of mRNA extremities in the parasitic protozoan Leishmania. BMC Bioinformatics (2008) 0.85
Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model. Immunotherapy (2012) 0.85
A national survey of occupational therapists' practices related to participation post-stroke. J Rehabil Med (2008) 0.85
Social participation of older adults in Quebec. Aging Clin Exp Res (2004) 0.85
DC-SIGN-mediated transfer of HIV-1 is compromised by the ability of Leishmania infantum to exploit DC-SIGN as a ligand. J Infect Dis (2005) 0.84
RNA polymerase I-mediated transcription of a reporter gene integrated into different loci of Leishmania. Mol Biochem Parasitol (2002) 0.84
Arm and leg impairments and disabilities after stroke rehabilitation: relation to handicap. Clin Rehabil (2003) 0.84
IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways. Allergy Asthma Clin Immunol (2013) 0.84
Emerging mediators of airway smooth muscle dysfunction in asthma. Pulm Pharmacol Ther (2012) 0.83
A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes. Mol Biochem Parasitol (2007) 0.83
Selective inactivation of SIDER2 retroposon-mediated mRNA decay contributes to stage- and species-specific gene expression in Leishmania. Mol Microbiol (2010) 0.83
Social participation of relatives post-stroke: the role of rehabilitation and related ethical issues. Disabil Rehabil (2010) 0.83
Impacts of wheelchair acquisition on children from a person-occupation-environment interactional perspective. Disabil Rehabil Assist Technol (2012) 0.83
Characterization of hibernating ribosomes in mammalian cells. Cell Cycle (2011) 0.82
Novel features of a PIWI-like protein homolog in the parasitic protozoan Leishmania. PLoS One (2012) 0.82
Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice. Exp Parasitol (2007) 0.82
Validation of a new lower-extremity motor coordination test. Arch Phys Med Rehabil (2005) 0.82
An Alba-domain protein contributes to the stage-regulated stability of amastin transcripts in Leishmania. Mol Microbiol (2013) 0.81
Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae. Parasitol Res (2011) 0.81
Altered expression of an RBP-associated arginine methyltransferase 7 in Leishmania major affects parasite infection. Mol Microbiol (2014) 0.81
Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients. Indian J Med Res (2009) 0.80
A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers. Drug Deliv (2013) 0.80
Long-term changes in participation after stroke. Top Stroke Rehabil (2006) 0.80
Outcomes during and after inpatient rehabilitation: comparison between adults and older adults. J Rehabil Med (2008) 0.80
Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells. Sci Rep (2013) 0.79
Cell homeostasis in a Leishmania major mutant overexpressing the spliced leader RNA is maintained by an increased proteolytic activity. Int J Biochem Cell Biol (2010) 0.79
Perceived impacts of a first wheelchair on social participation. Disabil Rehabil Assist Technol (2011) 0.78
Analysis of membrane-enriched and high molecular weight proteins in Leishmania infantum promastigotes and axenic amastigotes. J Proteome Res (2012) 0.78
Impact of mild stroke on the quality of life of spouses. Int J Rehabil Res (2011) 0.78
Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis. Mol Biochem Parasitol (2004) 0.77
Stage-specific expression of the glycine cleavage complex subunits in Leishmania infantum. Mol Biochem Parasitol (2009) 0.77
[Studies on the parasite Leishmania in the post-genomic era]. Med Sci (Paris) (2003) 0.77
Driving poststroke: problem identification, assessment use, and interventions offered by canadian occupational therapists. Top Stroke Rehabil (2010) 0.77
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate. PLoS Negl Trop Dis (2013) 0.76
C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c mice. PLoS Negl Trop Dis (2011) 0.76
A flexible and low-cost polypropylene pouch for naked-eye detection of herpes simplex viruses. Analyst (2015) 0.76